- Full Year 2023 AddLife AB Earnings Call TranscriptFeb 02, 2024kr65.25Earnings
- Q3 2023 AddLife AB Earnings Call TranscriptOct 26, 2023kr65.25Earnings
- AddLife AB Capital Markets Day TranscriptSep 15, 2023
- Q2 2023 AddLife AB Earnings Call TranscriptJul 14, 2023kr116Earnings
- Q1 2023 AddLife AB Earnings Call TranscriptApr 26, 2023kr98.6Earnings
- Full Year 2022 AddLife AB Earnings Call TranscriptFeb 02, 2023kr108.2Earnings
- Q3 2022 AddLife AB Earnings Call TranscriptOct 27, 2022kr124.2Earnings
- Q2 2022 AddLife AB Earnings Call TranscriptJul 15, 2022kr157.2Earnings
- Q1 2022 AddLife AB Earnings Call TranscriptApr 28, 2022kr263.6Earnings
- Q4 2021 AddLife AB Earnings Call TranscriptFeb 04, 2022kr193.5 (-26.03%)Earnings
- Nine Months 2021 AddLife AB Earnings Call TranscriptOct 22, 2021kr339.6Earnings
- Half Year 2021 AddLife AB Earnings Call TranscriptJul 15, 2021kr282.6 (-5.93%)Earnings
- Q1 2021 AddLife AB Earnings Call TranscriptApr 28, 2021kr213.3Earnings
- AddLife AB acquires Healthcare 21 Group Call TranscriptApr 12, 2021
- AddLife AB Acquisition of Vision Ophthalmology Group GmbH Conference Call TranscriptApr 08, 2021
- Full Year 2020 AddLife AB Earnings Call TranscriptFeb 03, 2021kr145.4Earnings
- Nine Months 2020 AddLife AB Earnings Call TranscriptOct 21, 2020kr145.5 (+3.43%)Earnings
- Half Year 2020 AddLife AB Earnings Call TranscriptJul 17, 2020kr131 (+11.97%)Earnings
- Q1 2020 AddLife AB Earnings Call TranscriptApr 28, 2020kr78.88Earnings
- Full Year 2019 AddLife AB Earnings Call TranscriptFeb 06, 2020kr76 (+3.40%)Earnings
- Half Year 2019 AddLife AB Earnings Call TranscriptJul 12, 2019kr70.75 (-1.74%)Earnings
- Q1 2019 AddLife AB Earnings Call TranscriptMay 10, 2019kr62 (+3.33%)Earnings
Q1 2022 AddLife AB Earnings Call Transcript
()-&
My name is Kristina Willgard. I'm very happy to present to you the interim report. I think it's a very strong report for the first quarter. And if we look on the highlights for this quarter, we did right -- it was a successful quarter because still, I think we do a very good -- both sales growth but also a profit growth in this quarter. You see when you look into the report that the acquisitions are driving the sales in Medtech, which is actually exactly what we expected. You know that we have done a lot of acquisitions during the last 2 years within our MedTech business area. If we exclude the sales with COVID-19 products, we actually had an underlying organic growth of 5% in this quarter, which I think also is very strong. And both business areas actually had a positive growth, excluding COVID sales. We have completed 2 acquisitions in the quarter that was of MBA and Telia and another 2 was finalized after the quarter, and that was OâFlynn and BioCat.
So summarizing this quarter, we had
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)